Bruker Corporation
BRKR
NASDAQ·Healthcare·Medical - Devices·Mkt cap $8.9B
$58.50
▼ -1.53%
P/E
-151.16
Mkt Cap
$8.9B
52-Wk Range
$29.84–$65.30
52-Week Range
$29.84 - $65.30
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 89.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
2 risks
- Average volatility.
- Premium valuation to sector peers
Growth
Turning profitable
Value
Premium valuation to sector peers
Momentum
Stable
+4.0% over 3m
Quality
Strong
Strong fundamentals
Dividend
Token
0.34% yield
Smart-money signal
Who's buying BRKR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 2, 2026
AUG 4, 2026
Reported EPS of $0.49 vs $0.38 consensus (+27.3% surprise). Revenue of $838.5M vs $853.6M expected (-1.8%).
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+27.3%
Revenue trend · last 2Q
—
+5%
Q1 26
Q2 26
$823.4M
$838.5M
Margins · last 2Q
Gross
48.5%
Operating
-11.9%
Profit
-8.8%
Wall Street consensus
5 analysts · 40% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
40%
Hold
60%
Sell
0%
Median Price Target
$70.00
▲ +19.7% vs $58.50
Latest: TD Cowen · Jul 15, 2026
1 analyst covering
vs Industry
How BRKR stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.